Peer Exchange

EP. 1: 2017 Changes to the McDonald Criteria: Diagnosing Multiple Sclerosis

EP. 2: Use of MRI in Diagnosing Multiple Sclerosis

EP. 3: Misdiagnosis of Multiple Sclerosis

EP. 4: Cerebrospinal Fluid in Diagnosing Multiple Sclerosis

EP. 5: Challenges in Optimally Treating Multiple Sclerosis

EP. 6: QoL Issues in the Management of Multiple Sclerosis

EP. 7: Multiple Sclerosis Fatigue

EP. 8: TRIUMPHANT-MS Trial: Fatigue in MS

EP. 9: OPTIMUM Phase 3 Trial: Secondary End Point Effect on Fatigue

EP. 10: Strategies for Choosing Initial Therapy in MS

EP. 11: Anti-CD20 Monoclonal Antibodies for Treatment of RMS

EP. 1: Unmet Needs in the Management of Migraine

EP. 2: Acute Treatment of Migraine: Traditional Therapies

EP. 3: Evolution of Acute Treatment of Migraine

EP. 4: Acute Treatment of Migraine: Progress With Novel Medications

EP. 5: Use of 5-HT1F Agonists in Acute Treatment of Migraine

EP. 6: Safety of CGRP Receptor Antagonists vs 5-HT1F Agonists

EP. 7: Intranasal DHE in Acute Treatment of Migraine

EP. 8: Patient Selection of Novel Therapies for Migraine Treatment

EP. 9: Role of Neuromodulation for Acute Treatment of Migraine

EP. 10: Patient Selection for Neuromodulation Devices

EP. 11: Behavioral and Lifestyle Strategies for Migraine Management

EP. 1: Diagnosis of Multiple Sclerosis: The McDonald Criteria

EP. 2: Differential Diagnosis of Multiple Sclerosis

EP. 3: MOG-IgG in Multiple Sclerosis

EP. 4: Clinically Isolated Syndrome Versus Multiple Sclerosis

EP. 5: First-Line Therapies for Relapsing Multiple Sclerosis

EP. 6: The Use of Interferon in Multiple Sclerosis

EP. 7: The Use of Glatiramer Acetate in Multiple Sclerosis

EP. 8: Clinical Trials for Cladribine in Multiple Sclerosis

EP. 9: Treating With Cladribine in Multiple Sclerosis

EP. 10: Role of Siponimod in Multiple Sclerosis

EP. 11: Ocrelizumab for the Treatment of Multiple Sclerosis

EP. 12: Role of Ocrelizumab in Europe for Multiple Sclerosis

EP. 13: Role of Diroximel Fumarate in Multiple Sclerosis

EP. 14: Role of Ozanimod in Multiple Sclerosis

EP. 15: Switching Therapies in Multiple Sclerosis

EP. 16: Decision-Making Process for Treating Multiple Sclerosis

EP. 17: The Future of Treating Multiple Sclerosis

EP. 1: Cardiac Amyloidosis Diagnostic Workup

EP. 2: Hypertrophic Cardiomyopathy Historical Prognosis

EP. 3: AL and ATTR Diagnosis: Echo and Noncardiac Biopsy

EP. 4: When Are Heart Biopsies Warranted?

EP. 5: Technetium Pyrophosphate Scan Benefits

EP. 6: Monoclonal Protein Testing and Wild-Type ATTR

EP. 7: Technetium Pyrophosphate Scan Prior to TAVR

EP. 8: AL and ATTR Survival Metrics

EP. 9: Poor Toleration: AL and ATTR Treatment Modification

EP. 10: Cardioversion and Atrial Fibrillation Ablation

EP. 11: Cardiac Amyloidosis: Pacemakers and Defibrillators

EP. 12: Therapy Selection for Congestive Heart Failure

EP. 13: Available ATTR Selective Stabilizers

EP. 14: Cardiomyopathy Management: NSAID Options

EP. 15: TTR Gene Silencers as Cardiomyopathy Treatment

EP. 16: Developing Agents for Cardiac Amyloidosis Management

EP. 1: Overview of Spinal Muscular Atrophy

EP. 2: Phenotypes of Spinal Muscular Atrophy

EP. 3: Newborn Screening for Spinal Muscular Atrophy

EP. 4: Genetic Testing for Spinal Muscular Atrophy

EP. 5: Motor Testing to Assess Patients With SMA

EP. 6: Involvement of Primary Care Physicians in Diagnosing SMA

EP. 7: Pulmonary Care for Patients With Spinal Muscular Atrophy

EP. 8: GI Complications in Patients With Spinal Muscular Atrophy

EP. 9: Multidisciplinary Approach to Treating SMA

EP. 10: Recent Approval of Zolgensma for SMA

EP. 11: STR1VE Trial of Onasemnogene Abeparvovec for SMA

EP. 12: SPR1NT Trial of Onasemnogene Abeparvovec for SMA

EP. 13: Nusinersen for Treatment of SMA

EP. 14: Nusinersen ENDEAR-SHINE and CHERISH-SHINE for SMA

EP. 15: Nusinersen Phase 2 NURTURE Trial for SMA

EP. 16: Risdiplam in Development for SMA

EP. 17: Clinical Trials for Risdiplam for SMA

EP. 18: Final Thoughts on Treating SMA

EP. 1: Overview of Excessive Daytime Sleepiness

EP. 2: Overview of Narcolepsy

EP. 3: Signs and Symptoms of Narcolepsy

EP. 4: Narcolepsy Type 1 and Type 2

EP. 5: Diagnosis of Narcolepsy

EP. 6: Goals of Therapy in Narcolepsy

EP. 7: Nonpharmacologic Therapies for Narcolepsy

EP. 8: Laboratory Testing in Patients with Narcolepsy

EP. 9: Traditional Treatments for Narcolepsy

EP. 10: Pitolisant: Recently FDA Approved for Narcolepsy

EP. 11: Solriamfetol: Recently FDA Approved for Narcolepsy

EP. 12: Deciding Which Drug to Use in Narcolepsy

EP. 13: Insurance Coverage For Drugs to Treat Narcolepsy

EP. 14: Patient Resources Including the Narcolepsy Network

EP. 15: Drugs in Development for Treatment of Narcolepsy

EP. 16: Unmet Needs in the Treatment of Narcolepsy

EP. 17: Advice for Community Physicians Treating Narcolepsy

EP. 18: Referral to a Sleep Specialist to Treat Narcolepsy

EP. 19: Final Thoughts on Treating Narcolepsy

Peer Exchange

Updates in the Management of Relapsing Multiple Sclerosis

Advances in the Management of Acute Treatment of Migraine

Global Approaches to the Management of Relapsing Multiple Sclerosis

Management of Cardiac Amyloidosis

Advances in the Treatment of Spinal Muscular Atrophy

Management of Narcolepsy and Excessive Daytime Sleepiness